Tenax Therapeutics
(NASDAQ) TENX
Tenax Therapeutics Financials at a Glance
Market Cap
$258.22M
Revenue (TTM)
$0.00
Net Income (TTM)
$52.60M
EPS (TTM)
$-1.34
P/E Ratio
-11.24
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Price
$15.02
Volume
11,830
Open
$15.44
Price
$15.02
Volume
11,830
Open
$15.44
Previous Close
$15.02
Daily Range
$14.81 - $15.90
52-Week Range
$4.63 - $18.38
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Price
$15.02
Volume
11,830
Open
$15.44
Previous Close
$15.02
Daily Range
$14.81 - $15.90
52-Week Range
$4.63 - $18.38
TENX News
TENX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Tenax Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
16
CEO
Christopher T. Giordano
Website
www.tenaxthera.comHeadquarters
Chapel Hill, NC 27560, US
TENX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-56%
Return on Capital
-58%
Return on Assets
-50%
Earnings Yield
-8.90%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$258.22M
Shares Outstanding
17.20M
Volume
11.83K
Short Interest
0.00%
Avg. Volume
341.60K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$56.38M
EBITDA
$56.38M
Operating Cash Flow
$35.80M
Capital Expenditure
$0.00
Free Cash Flow
$35.80M
Cash & ST Invst.
$97.56M
Total Debt
$0.00
Tenax Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$258.22M
N/A
Market Cap/Employee
$64.56M
N/A
Employees
4
N/A
Net Income
$15.54M
-148.0%
EBITDA
$37.06M
+691.3%
Quarterly Fundamentals
Net Cash
$97.56M
+2.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-50.47%
N/A
Return on Invested Capital
-58.09%
N/A
Free Cash Flow
$13.41M
-280.3%
Operating Cash Flow
$13.41M
-280.3%